출처: Block Media
Upbit Lists Bioprotocol (BIO) Token: Key Details and Implications
Upbit, recognized as one of South Korea's top cryptocurrency exchanges, officially announced the listing of Bioprotocol (BIO) on October 20. This new addition further enhances its robust trading ecosystem. BIO will be available for trading across three major markets: KRW, BTC, and USDT. Trading activities are set to commence at 6:00 PM KST, marking a significant milestone for both the exchange and the token itself.
BIO Listing Details and Ethereum-Based Support
To facilitate seamless transactions, deposits and withdrawals for BIO are supported using the Ethereum network. This functionality went live promptly at 5:35 PM KST on October 20, just hours after Upbit's official announcement. Users keen to interact with BIO should note its designated contract address: 0xcb1592591996765ec0efc1f92599a19767ee5ffa.
For added clarity, this Ethereum contract ensures secure and transparent transactions, aligning with the blockchain principles that underpin BIO's operations. This early support highlights Upbit's commitment to delivering accessibility and reliability as cryptocurrency trading continuously evolves.
Initial Trading Regulations: A Controlled Rollout
Upbit has implemented initial trading restrictions for BIO to maintain market stability during its launch phase. These measures aim to optimize trading dynamics and protect both new and existing investors.
-
Restricted Buy Orders:
Within the first five minutes of BIO trading, users will be unable to place buy orders. This ensures a smoother introduction to the trading markets. -
Sell Price Restrictions:
Sell orders priced 10% or more below BIO's previous day’s closing price of 118.09 KRW will be prohibited. This measure is designed to prevent sudden, dramatic price fluctuations and maintain investor confidence. -
Limit Order Requirement:
For the first two hours post-launch, only limit orders will be accepted. This protocol allows traders to set specific price points, offering more predictability amid initial market activity.
As per Upbit's latest updates at 3:15 PM KST on October 20, BIO had an indicative trading price of approximately 120.04 KRW. This steady valuation signals positive market sentiment and sets the stage for BIO's trading debut.
Understanding Bioprotocol (BIO)
Bioprotocol is an innovative blockchain-driven project aiming to revolutionize financing in the biotechnology sector. Acting as a decentralized financial infrastructure, the platform empowers early-stage biotech innovators by ensuring transparent funding and commercialization solutions. Its comprehensive support spans the entire lifecycle of biotech development, encompassing research planning, funding acquisition, and final commercialization.
Key Features of the Bioprotocol Ecosystem
Bioprotocol's unique framework includes cutting-edge, blockchain-based modules:
- Bio DAO: A decentralized autonomous organization designed to democratize decision-making processes within biotech financing.
- IP-Token: A specialized token system that enables biotech intellectual property to be tokenized, fostering seamless commercialization and investment opportunities.
Functionality of BIO Token
The BIO token forms the backbone of the Bioprotocol network by fulfilling a range of roles:
- Staking: Users can lock BIO tokens to participate in governance activities or earn rewards, incentivizing community engagement.
- Governance: Token holders are granted voting rights to influence key decisions within the Bioprotocol ecosystem, ensuring a democratic structure.
- Biotech Investments: The token provides access to funding opportunities for promising biotech projects, accelerating innovation in the industry.
Through these functionalities, BIO and the Bioprotocol platform aim to bring transparency, inclusivity, and efficiency to a traditionally complex funding ecosystem. By embracing decentralized finance (DeFi), Bioprotocol champions accessibility for researchers, investors, and stakeholders.
Conclusion
The listing of Bioprotocol (BIO) on Upbit represents a pivotal step for this emerging cryptocurrency and its ambitious biotech financing goals. With deposit and withdrawal support on the Ethereum network, initial trading regulations ensuring stability, and a well-defined mission, BIO is well-positioned to drive significant advancements in the biotechnology sector. Upbit's decision to list BIO further underscores the potential for blockchain to transform traditional industries, opening new doors for decentralized innovation on a global scale.
